Zealand Pharma has shared primary endpoint data on Roche-partnered petrelintide, revealing that the middle dose of the amylin analog delivered the highest weight loss—9.8%—at Week 28.
Zealynx Academy is live.
A platform for Web3 founders:
- Guides to fork DeFi protocols with awareness
- Security training to build safer Smart Contracts
- MBA-level knowledge to grow your protocol into a business
- Build AI Agents to grow your company
Free, no paywall.
New Zealand's High Court has struck down regulations banning new prescriptions of puberty blockers for adolescents with gender dysphoria, ruling that the measures were made unlawfully and amounted to unjustified discrimination
New Zealand’s annual inflation slowed more than expected in the third quarter as fuel prices retreated, offering a brief respite to the government little more than two weeks from an election.